The second edition of our campus case study competition, 'Destination Dr. Reddy's' is now LIVE! 🎉 Our purpose of 'Good Health Can't Wait' means keeping patients at the heart of our work. With this mind, for the second year in a row, we're eager to invite and engage with bright young minds and future leaders of healthcare from management, engineering, and pharmacy universities to participate in our case study competition to solve real-life healthcare challenges with fresh, innovative thinking. Register now: https://bit.ly/3y1A3dr. Exciting prizes and PPI opportunities for internship are up for grabs! #GoodHealthCantWait #WeAreDrReddys #CaseStudyCompetition
Dr. Reddy's Laboratories
Pharmaceutical Manufacturing
Hyderabad, TS 1,196,366 followers
We accelerate access to affordable and innovative medicines because Good Health Can’t Wait.
About us
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of ‘Good Health Can’t Wait’, we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to complianceofficer@drreddys.com or chiefombudsperson@drreddys.com.
- Website
-
http://www.drreddys.com
External link for Dr. Reddy's Laboratories
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Hyderabad, TS
- Type
- Public Company
- Founded
- 1984
- Specialties
- pharmaceutical, specialty, biogeneric, API, and generic formulations
Locations
Employees at Dr. Reddy's Laboratories
Updates
-
Congratulations to CEO - Aurigene Pharmaceutical Services Limited, Akhil Ravi for featuring in Economic Times' 40 under 40 leaders - a recognition of leaders from corporate India creating business impact, contibuting to the ecosystem, and their relative position in the industry.
🌟 Exciting News! 🌟 We are thrilled to announce that our CEO, Akhil Ravi, has been named one of India's brightest young business leaders by Economic Times 𝟰𝟬 𝗨𝗡𝗗𝗘𝗥 𝗙𝗢𝗥𝗧𝗬! 🏆. This recognition is a testament to Akhil's exceptional leadership and dedication to driving our company forward. Akhil's visionary approach and commitment to excellence have been instrumental in our growth and success. This accolade is not just a personal achievement for Akhil but a proud moment for all of us at Aurigene Pharmaceutical Services Limited. Join us in congratulating Akhil on this well-deserved honor! 🎉 #Leadership #Achievement #40Under40 #ProudMoment
-
-
We are pleased to have partnered with the Indian Medical Association (IMA) as scientific partner on the release of a special booklet called ‘Headache Algorithm: A guide to Headache Management'. The booklet, made by specialists for specialists, focuses on the comprehensive management of headache disorders in India. It is part of the IMA's medical initiative, coming at a crucial time when headache management is a leading cause of neurological disability globally. Through this booklet, the IMA aims to highlight the prevalence of headache disorders and especially migraine, explore its causes, and provide insights into its diagnosis and management. With dedicated sections on primary and secondary headache management, considerations regarding red flags, appropriate times for specialist referral, and the appropriate use and positioning of abortive and preventive treatments, the booklet offers evidence-based strategies for clinicians to tailor their treatment approaches accordingly. To enhance informed decision-making in clinical practice, the booklet also includes decision algorithms for diagnosis, and management of different types of headaches and headache disorders with other different comorbidities. #GoodHealthCantWait #WeAreDrReddys #IMA #Beyond100
-
-
Dr. Reddy's Laboratories reposted this
At the 9th GPQS 2024, GV Prasad, Co-Chairman & MD of Dr. Reddy's Laboratories, emphasised patient centricity in healthcare, the role of technology, and stressed the need for greater recognition and celebration of the Indian pharma industry's achievements. Read more: https://lnkd.in/d8nV_8FR #IPA #GPQS2024 #PharmaIndustry #PharmaIndia #PatientCentricity #Manufacturing #Quality
-
The moment you have been waiting for is finally here! Dr. Reddy's presents to you DESTINATION DR. REDDY'S. A unique opportunity for MBA, Engineering, and M.Pharma students to prove their prowess and shine. This is your chance to innovate and get ahead in the game. Exciting prizes and PPI opportunities up for grabs along with braggin right! Stay tuned for more!
-
-
In our profession, we generally hear about or work on different approaches for developing leaders within organizations. However, very little emphasis is paid on how to focus on individual transformation of leaders - uncomplicating the past; reconciling with our 'baggage', or just understanding (and accepting) what makes us, us. At Dr. Reddy's Laboratories, our New Horizon Leadership Program (NHLP) caters to this specific need of helping leaders assume their role as productive individuals in the broader society. We recently closed the 2023-24 cohort, marking the 12th consecutive year of delivering this program. This year's graduating cohort comprised of leaders from across our business units, geographies and manufacturing sites. Over the program duration, they acquired tools & techniques to become a more reconciled version of self, live more harmoniously with their surroundings and thereby achieve exponentially more - at work and in their personal lives. With extensive support from our Program Sherpas Adiba Ahmed and Sumana Kandukuri, our Financial Wizard Syed Shakeer Basha, sponsors and coaches, these leaders aim for breakthrough business impact by evolving from being a role, to being a true leader. Want to talk about a similar challenge around developing well rounded leaders? Adiba Ahmed, Sumana Kandukuri and I will be happy to share our learning in greater detail. Stay tuned for more updates on our journey towards building a hashtag #future where #GoodHealthCantWait! #PersonalTransformation #drreddyslaboratories #leadershipdevelopment #FromDoingtoBeing #LeadersForTheFuture #BeATrueLeader #DrReddysLaboratories #FutureCapabilities #LifeLongLearning #OnStrategy #learninganddevelopment #CapabilityDevelopment #LearningExperience #40yearsofDrReddys #WeAreDrReddys #GoodHealthCantWait #NHLP #NewHorizons Debasis Rath Shiksha Pathak Syed Shakeer Basha Himanshu Yadav Vishal Shankar Devesh Awasthi Blessy Cherian Dr. Shridevi Venkataramani
-
-
We are pleased to welcome Meenakshi Chhajer into the Dr. Reddy’s family as our Head DPEx- Supply Chain & Global Procurement. Meenakshi has over 16 years of experience in business operations, technology platforms, and digital product capabilities. She has played pivotal roles in leading digital transformations globally across the procurement, finance, and supply chain functions enabling enterprise wide intelligent decisions. We look forward to having Meenakshi lead the digitization and excellence journey at Dr Reddy's and wish her the very best. #GoodHealthCantWait #WeAreDrReddys
-
-
It was a pleasure to host the 33rd National Symposium of the Chemical Research Society of India (CRSI) at our Bachupally premises in Hyderabad. The unique event brought together eminent scientists, young researchers, and technologists across academia and industry. The aim was to facilitate discussions on achievements and new research directions in chemical and allied sciences, contributing to the pursuit and promotion of chemistry for the service of humanity. The symposium also aimed to foster industry-academia collaborations for future advancements in chemistry. It was attended by several luminaries from the field of Chemistry, along with representatives from various institutions, industry and students. Our Co-Chairman and MD, Prasad G V delivered the welcome speech at the event. CRSI represents more than 3,000 lifetime members who participate in the study, practice, teaching and promotion of Chemistry. The three-day event witnessed a heartening response with over 350 delegates from the field of Chemistry and 120 poster presentations. It concluded with an awards ceremony and announcement of the venue for the next CRSI NSC (34th edition) at IISER Bhopal in the first week of February, 2025. #GoodHealthCantWait #WeAreDrReddys #33CSRISymposium #DeepScience
-
-
-
-
-
+1
-
-
Dr. Reddy's Laboratories reposted this
📣 Webinar on-demand: Commercialising Cell and Gene Therapy bought to you by Citeline & the Indian Pharmaceutical Alliance (IPA). Watch now: https://ow.ly/suYb50StXvn. This illuminating webinar looks at one of the most active areas of research and investment in the development of medicine, Cell and Gene Therapy (CGT). The promising advancements in CGT present groundbreaking options for treating diseases like cancer, leading to tailored and affordable healthcare solutions for patients. Featuring Shridhar Narayanan - Technical Advisor, IPA , Pooja Rana - Senior Consultant at Citeline, Murali Ramachandra - CEO Aurigene and Rahul Purwar - Founder of ImmunoACT. #CellAndGeneTherapy #CancerTreatment #HealthcareInnovation #MedicalResearch #PharmaceuticalAlliance #BiotechAdvancements #WebinarReplay #IndianPharma
-
-
Our manufacturing team in Bachupally, Hyderabad has won two Platinum and two Silver Kaizen Awards at the 49th CII TPM National level Kaizen Competition in various Kaizen categories. The Kaizen Award recognises organisations for their implementation of Kaizen principles and practices. The award program helps organisations evaluate their performance, identify areas for improvement, and assess their current level of excellence. The award ceremony was held on 27-28th June 2024 at Bangalore. A total of 162 Kaizen teams from 100 different companies across Automobile, Steel, FMCG, Oil & Gas, Pharma, Chemical, IT industries participated in the Kaizen competition. Congratulations to our team for emobodying our commitment to continuous improvement, and operational efficiencies in quality, cost and delivery! #GoodHealthCantWait #WeAreDrReddys #KaizenAwards
-